Akifumi Ichiki
Overview
Explore the profile of Akifumi Ichiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawai H, Matsushita H, Kawakami S, Furuya D, Shiraiwa-Hara S, Ichiki A, et al.
J Clin Exp Hematop
. 2019 Mar;
59(1):34-39.
PMID: 30918142
Composite lymphoma (CL) is defined as the occurrence of two distinct types of lymphoma within the same patient. Most cases of CL involve Hodgkin and non-Hodgkin lymphomas or two distinct...
2.
Amaki J, Sekiguchi T, Hiraiwa S, Kajiwara H, Kawai H, Ichiki A, et al.
Int J Hematol
. 2018 Aug;
108(6):647-651.
PMID: 30144001
Spontaneous splenic rupture is a rare but often life-threatening condition. However, there is no consensus on appropriate management for this condition, due to its rarity. Here, we report three cases...
3.
Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier
Ichiki A, Carreras J, Miyaoka M, Kikuti Y, Jibiki T, Tazume K, et al.
J Clin Exp Hematop
. 2017 Oct;
57(2):54-63.
PMID: 29021515
The estimation of clinical prognosis for diffuse large B-cell lymphoma (DLBCL) with a quick, cost-efficient method is necessary because of the clinical heterogeneity of this disease, which leads to death,...
4.
Miyaoka M, Y Kikuti Y, Carreras J, Ikoma H, Hiraiwa S, Ichiki A, et al.
Mod Pathol
. 2017 Oct;
31(2):313-326.
PMID: 28984304
Most high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements are aggressive B-cell lymphomas. Occasional double-hit follicular lymphomas have been described but the clinicopathological features of these tumors are...
5.
Onizuka M, Kojima M, Matsui K, Machida S, Toyosaki M, Aoyama Y, et al.
Int J Hematol
. 2017 Jan;
106(1):141-145.
PMID: 28097534
Previous studies have reported that an antibody that blocks programmed cell death 1 (PD-1) has therapeutic activity in patients with refractory/relapsed Hodgkin lymphoma (HL). However, the safety and efficacy of...
6.
Carreras J, Y Kikuti Y, Bea S, Miyaoka M, Hiraiwa S, Ikoma H, et al.
Histopathology
. 2016 Oct;
70(4):595-621.
PMID: 27775850
Aims: We aimed to define the clinicopathological characteristics of 29 primary sinonasal diffuse large B cell lymphoma (DLBCL ) in a series of 240 cases of DLBCL not otherwise specified...
7.
Ichiki A, Hashimoto N, Ueda T, Hiraiwa S, Tajiri T, Nakamura N, et al.
Intern Med
. 2016 Aug;
55(16):2295-9.
PMID: 27523012
A 61-year-old Japanese woman with anemia, submandibular gland swelling, and enlarged lymph nodes was diagnosed with IgG4-related disease (IgG4-RD) by lymph node biopsy. Bone marrow involvement of IgG4-RD was detected...
8.
Kojima M, Ogiya D, Ichiki A, Hara R, Amaki J, Kawai H, et al.
Leuk Res Rep
. 2016 May;
5:11-3.
PMID: 27144119
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As2O3), conventional chemotherapy, and autologous peripheral blood stem cell transplantation. We...
9.
Amaki J, Onizuka M, Ohmachi K, Aoyama Y, Hara R, Ichiki A, et al.
Int J Hematol
. 2015 Mar;
101(6):543-53.
PMID: 25735499
Cytarabine arabinoside (Ara-C) is the most important agent for treating acute myeloid leukemia (AML). Here, we genotyped 11 single nucleotide polymorphisms (SNPs) of seven Ara-C metabolism-related genes in 39 AML...
10.
Sato A, Nakamura N, Kojima M, Ohmachi K, Carreras J, Kikuti Y, et al.
Cancer Sci
. 2014 Jul;
105(9):1170-5.
PMID: 24974976
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma. The incidence of Epstein-Barr virus (EBV)-positive DLBCL in Asian and Latin American countries ranges from 8 to...